Implications of Sarcopenia and Glucometabolism Parameters of Muscle Derived From Baseline and End-of-Treatment < sup > 18 < /sup > F-FDG PET/CT in Diffuse Large B-Cell Lymphoma

CONCLUSION: Sarcopenic patients had lower muscle glucometabolism, and the muscular and metabolic changes across treatment were positively correlated. Sarcopenia at baseline and end-of-treatment was negatively associated with the prognosis of DLBCL.PMID:38413112 | PMC:PMC10912500 | DOI:10.3348/kjr.2023.0949

Source: Korean J Radiol - February 27, 2024 Category: Radiology Authors: Xiaoyue Tan Xiaolin Sun Yang Chen Fanghu Wang Yuxiang Shang Qing Zhang Hui Yuan Lei Jiang Source Type: research